Literature DB >> 4150137

The acetylator phenotype of patients with systemic lupus erythematosus.

M M Reidenberg, J H Martin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4150137

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  19 in total

Review 1.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

2.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

Review 3.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

Review 4.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

Review 5.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

6.  Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes.

Authors:  C A McQueen; C J Maslansky; I B Glowinski; S B Crescenzi; W W Weber; G M Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Polymorphic acetylation: lack of influence of rheumatic disease activity and concomitant drug administration.

Authors:  C Astbury; C Beyeler; H A Bird
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 8.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

9.  Acetylator phenotype in spontaneous SLE and rheumatoid arthritis.

Authors:  D H Lawson; D A Henry; J Lowe; P Reavey; J A Rennie; A Solomon
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

10.  Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus.

Authors:  S Chitrabamrung; R L Rubin; E M Tan
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.